A recent study on colorectal cancer reported the release of IL-6 and GM-CSF from cancer-associated fibroblasts, leading to the differentiation of monocytes into tumour-associated macrophages, resulting in an immunosuppressive tumour niche. This evidence concerns the gene CSF2 and cancer.